Terms: = Uterine cancer AND CIC, ENSG00000079432, 23152, Q96RK0, KIAA0306 AND Diagnosis
6 results:
1. Primary Synovial Sarcoma of the uterine Cervix: First Case Report.
Vaziri Fard E; Zhang S; El Achi HS; Covinsky M
Int J Gynecol Pathol; 2021 Mar; 40(2):196-203. PubMed ID: 33075021
[TBL] [Abstract] [Full Text] [Related]
2. Long-term evaluation of renal function and neurogenic bladder following radical hysterectomy in patients with uterine cervical cancer.
Komatsu H; Oishi T; Osaku D; Kudoh A; Shimogai R; Chikumi J; Sato S; Harada T
J Obstet Gynaecol Res; 2020 Oct; 46(10):2108-2114. PubMed ID: 32686280
[TBL] [Abstract] [Full Text] [Related]
3. SMARCA4 (BRG1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas.
Karanian-Philippe M; Velasco V; Longy M; Floquet A; Arnould L; Coindre JM; Le Naoures-Méar C; Averous G; Guyon F; MacGrogan G; Croce S
Am J Surg Pathol; 2015 Sep; 39(9):1197-205. PubMed ID: 26135561
[TBL] [Abstract] [Full Text] [Related]
4. Acute phase reactants and circulating immune complexes in patients with ovarian carcinoma.
Dobryszycka W; Gerber J; Zuwała-Jagiełło J; Ujec M
Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):41-50. PubMed ID: 1725104
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of circulating immune complexes (C.I.C.) in endometrial cancer.
Benedetti Panici P; Di Roberto P; Scambia G; Cauda R; Laghi V; Mancuso S; Bompiani A
Eur J Gynaecol Oncol; 1986; 7(1):27-9. PubMed ID: 3699057
[TBL] [Abstract] [Full Text] [Related]
6. Circulating IgG-specific immune complexes as a potential tumor marker in gynecological malignancies.
Dodd JK; Hicks LJ; Tyler JP; Crandon AJ; Hudson CN
Gynecol Oncol; 1983 Oct; 16(2):232-9. PubMed ID: 6629124
[TBL] [Abstract] [Full Text] [Related]
